drug – Page 2 – cannabis.co.nz

April 14, 2021Aaron Green, absorb, absorption, analysis, analytics, available, bioavailability, bioavailable, business, cannabinoid, cannabis, capsule, cbd, colloidal, compliance, consumer, cultivation, delivery, dispensary, drug, Edibles & Processing, emulsifying, emulsions, extraction, Federal, formulate, formulation, Geocann, government, gras, growing, hemp, industry, innovate, innovation, Iridium consulting, Jesse Lopez, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, lipid, liposomal, marijuana, market, mechanism, medical, medicine, micro, natural, oil, patent, patent protection, product, Product Development, Quality, recreational, regulation, regulations, regulatory, retail, safety, SEDDS, self-emulsifying drug delivery system, solubility, soluble, SourceOne Global Partners, state, Technology, test, Testing, thc, tincture, vesi, Vesifact, VESIsorb

Leaders in Cannabis Formulations: Part 2

Editor’s Note: In Part 1 of this series, green sat down with Drew Hathaway, senior food scientist at Stillwater Brands. Click here […]

March 26, 2021Act, active, advertised, advertising, analysis, analytics, and Cosmetic, approval, business, cannabidiol, cannabis, cbd, compliance, consumer, Dispensaries & Retail, drug, FDA, FDA food safety challenge, Federal, food, GMP, good manufacturing practice, government, growing, Husch Blackewell, inactive, industry, ingredient, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, marketing, medical, medicine, NDA, New Drug Application, nonprescription, OTC, prescription, product, products, Quality, recreational, regulation, regulations, regulatory, retail, safety, state, test, Testing, thc, violation, warning

FDA Issues Warning Letters on Marketing and Sale of OTC CBD Products

The U.S. Food and Drug Administration (FDA) issued warning letters this month to two companies concerning the marketing and sale of over-the-counter (OTC) drug […]

February 25, 2021analysis, analytics, business, cannabis, CAPA, cbd, cGMPs, compliance, compliant, consumer, cosmetics, CSA, cultivation, Current good manufacturing Practice, device, dietary supplements, dispensary, drug, Edibles & Processing, employee training, equipment design, extraction, facility design, FDA, Federal, food, GMP, GMPs, good manufacturing practice, government, growing, industry, Kathleen May, lab, laboratories, laboratory, labs, law, legal, legalization, legalize, marijuana, market, medical, medicine, Operations, product, Quality, regulation, regulations, regulatory, risk management, safety, schedule I, standard, state, Supply Chain, system, test, Testing, thc, Triskele Quality Solutions, USDA

GMPs & Cannabis Manufacturing

Editor’s Note: While CIJ typically omits the word “marijuana” where possible due to antiquated nomenclature and prejudicial connotations, we understand the legal […]

December 3, 20204, account, analysis, business, cannabis, classification, Commission for Narcotic Drugs, development, drug, EU, europe, European, export, Federal, global, government, growing, import, industry, international, law, legal, legalization, legalize, legislation, marijuana, market, medical, medicine, recommend, recommendation, recreational, regulation, regulations, regulatory, research, safety, Schedule IV, scheduling, state, The United Nations, Ukraine, UN, United States, USA, Vienna, vote, WHO, world, World Health Organization

UN Removes Cannabis From Schedule IV

The United Nations Commission for Narcotic Drugs, based in Vienna, Austria, voted to remove cannabis for medical use from its Schedule IV […]

October 28, 20201, analysis, analytics, and Cosmetics Act, application, approval, approve, business, Business Analysis, cannabidiol, cannabis, cbd, clinical, clinical trials, compliance, consumer packaged goods, CPG, CSA, dea, derived, deschedule, descheduled, Dravet syndrome, drug, Drug Enforcement Administration, Epidiolex, epilepsy, extraction, FDA, FDCA, Federal, Federal Food, FFDCA, food and drug administration, formulation, government, GW, GW Pharma, hemp, industry, law, legal, legalization, legalize, legislation, Lennox-Gastaut syndrome, license, marijuana, market, medical, medicine, New, patent, pathway, patient, pharma, pharmaceutical, product, Product Development, program, regulation, regulations, regulatory, REMS, safety, schedule, seizures, state, Substances, thc, trial, TSC

How GW Pharma Won CBD

As of this writing, the United States Food and Drug Administration (FDA) has approved GW Pharma’s CBD drug Epidiolex for treating profound […]

August 19, 20202018, action, analysis, analytics, argument, attorney, business, Business Analysis, california, cannabidiol, cannabis, case, cases, cbd, class, complaint, compliance, Concentrates & Extracts, consumer, cosmetic, court, cultivation, deadline, defendant, deferred, derived, dietary supplement, dismiss, Dispensaries & Retail, dispensary, drug, Edibles & Processing, ent, extraction, farm bill, FDA, FDCA, Federal, federal food drug and cosmetic act, file, florida, food, Goodwin, government, growing, hemp, industry, judge, judgement, jurisdiction, lab, laboratories, laboratory, labs, law, lawsuit, lawyer, legal, legalization, legalize, legislation, license, litigate, litigation, marijuana, market, massachusetts, medical, medicine, motion, pending, plaintiff, product, Product Development, products, prosecutor, pursuant, Quality, regulation, regulations, regulatory, retail, rulemaking, ruling, safety, scheme, state, stayed, sue, suit, test, Testing, thc, vacate

CBD You in Court: Consumer Class Actions Involving Hemp-Derived CBD Products

Consumer demand for products containing cannabidiol (CBD) is on the rise across the country, with industry experts estimating that the market for […]

July 15, 2020analysis, analytics, applicant, applicants, application, apply, business, Business Analysis, cannabis, compliance, consumer, demographic, drug, drug testing, employ, employee, employees, employer, fairness, Federal, government, hire, hiring, industry, job, law, legal, legalization, legalize, legislation, license, marijuana, medical, medicine, Operations, organization, Organizational, percieved, policies, policy, psychology, recreational, regulation, regulations, regulatory, state, survey, test, Testing, thc, train, training, usage, workplace

A Joint Problem: How Cannabis Testing Policies Affect Applicants’ Attraction Toward an Organization

Employees with substance abuse issues could cause problems for their employers. Recent legalization of cannabis has prompted organization to re-evaluate their drug […]